尼曼匹克C1样蛋白1及其与胆囊胆固醇结石形成关系的研究进展
被引量:1
摘要
脂质代谢异常与胆固醇结石病、动脉粥样硬化、冠心病等疾病发生关系密切。尼曼匹克C1样蛋白1(Niemann Pick C1 like 1,NPC1L1)是小肠参与胆固醇摄取的重要蛋白质[1],自其被发现以来,一直是研究和临床关注的热点。本文对NPC1L1蛋白及其基因多态性研究的最新成果作一综述,并对其在相关疾病治疗中的作用作一展望。
出处
《外科理论与实践》
2015年第3期262-265,共4页
Journal of Surgery Concepts & Practice
参考文献33
-
1Altmann SW, Davis HR Jr, Zhu LJ, et al. Niemann-PickCl Like 1 protein is critical for intestinal cholesterol ab-sorption[J]. Science,2004,303(5661): 1201-1204.
-
2Davies JP, Levy B, Ioannou YA. Evidence for a Nie-mann-pick C (NPC) gene family: identification and cha-racterization of NPC1L1[J]. Genomics,2000,65(2):137-145.
-
3Ninomiya H. Niemann-Pick Cl-Like 1: A key player inintestinal cholesterol absorption [J]. Yonago Acta Medica,2010,53(2):29-36.
-
4Wang U, Song BL. Niemann-Pick Cl-Like 1 and choles-terol uptake[J]. Biochim Biophys Acta,2012,1821 (7):964-972.
-
5Temel RE, Tang W, Ma Y, et al. Hepatic Niemann-PickCl-like 1 regulates biliary cholesterol concentration andis a target of ezetimibe[J]. J Clin Invest,2007,117(7): 1968-1978.
-
6Ahmed MH, Byrne CD. Potential therapeutic uses forezetimibe beyond lowering LDL-C to decrease cardiovas-cular events[J]. Diabetes Obes Metab,2010,12(11):958-966.
-
7Davies JP, Scott C,Oishi K,et al. Inactivation ofNPC 1 LI causes multiple lipid transport defects and pro-tects against diet-induced hypercholesterolemia [J]. J BiolChem,2005,280(13):12710-12720.
-
8Yu L, Bharadwaj S, Brown JM, et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitatesfree cholesterol uptake[J]. J Biol Chem,2006,281(10):6616-6624.
-
9Davis HR Jr, Zhu LJ, Hoos LM, et al Niemann-Pick Cl Like 1(NPC 1 LI) is the intestinal phytosterol and cholesterol trans-porter and a key modulator of whole-body cholesterol home-ostasis[J]. J Biol Chem,2004,279(32):33586-33592.
-
10Huang Y, Zheng Y. The probiotic lactobacillus aci-dophilus reduces cholesterol absorption through thedown-regulation of Niemann-Pick Cl-like 1 in Caco-2cells[J]. Br J Nutr,2010,103(4):473-478.
二级参考文献15
-
1Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data [J]. Lancet, 2006, 367(9524): 1747-1757.
-
2Wang Q. Molecular genetics of coronary artery disease[J]. Curr Opin Cardiol, 2005, 20(3): 182-188.
-
3Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids[J]. Nature, 2010, 466(7307): 707-713.
-
4Chen CW, Hwang JJ, Tsai CT, at al. The g.-762T>C polymorphism of the NPC1L1 gene is common in Chineseand contributes to a higher promoter activity and higher serum cholesterol levels [J]. J Hum Genet, 2009, 54(4): 242-247.
-
5Kathiresan S, Manning AK, Demissie S, et al. A genomewide association study for blood lipid phenotypes in the Framingham heart study [J]. BMC Med Genet, 2007, 8 Suppl 1: S17.
-
6Willer C J, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease[J]. Nat Genet, 2008, 40(2): 161-169.
-
7Ahmann SW, Davis HR Jr, Zhu IJ, et al. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption[J]. Science, 2004, 303(5661): 1201-1204.
-
8Martin B, Solanas-Barca M, Garcla-Otin AL, et al. An NPC1L1 gene promoter variant is associated with autoso- mal dominant hypercholesterolemia [J]. Nutr Metab Cardiovasc Dis, 2010, 20(4): 236-242.
-
9Wang LJ, Wang J, Li N, et al. Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbers[J]. J Biol Chem, 2011, 286(9): 7397-7408.
-
10Simon JS, Karnoub MC, Devlin DJ, et al. Sequence variation in NPC1L1 and association with improved EDL- cholesterol lowering in response to ezetimibe treatment[J].Genomies, 2005, 86(6): 648-656.
同被引文献6
-
1杨玉龙,刘小北,谭文翔,李雪驼.胆固醇结石中的细菌及其在成石机制中的作用[J].肝胆胰外科杂志,2005,17(1):14-16. 被引量:11
-
2肖南方,张明珠,方驰华.胆囊结石患者胆囊黏膜需氧菌和厌氧菌的分子生物学研究[J].新医学,2001,32(1):29-30. 被引量:3
-
3邓量,梁明懿,张昆松,许峰峰,黎文峰,张继红.ABCG5和ABCG8基因在胆囊胆固醇结石和胆固醇息肉形成中的作用[J].中华肝脏外科手术学电子杂志,2015,4(2):57-60. 被引量:9
-
4谢经丰,王永芹,袁晟光.胆汁酸与肠道菌群及其相互影响在肝再生中的作用研究进展[J].肝胆胰外科杂志,2018,30(1):87-89. 被引量:10
-
5苏爱美,魏绍春.胆道疾病患者胆汁菌群分布及耐药分析[J].中华实验和临床感染病杂志(电子版),2017,11(6):607-612. 被引量:6
-
6孙家昌,孙妩弋,厉歆然,彭文婷,魏伟.G蛋白偶联受体与肝损伤的研究现状[J].中国临床药理学杂志,2018,34(8):1000-1004. 被引量:2
二级引证文献5
-
1冯亚锋,王国辉.手术室护理干预在胆结石腹腔镜治疗患者中的应用效果[J].临床医学研究与实践,2021,6(24):178-180. 被引量:13
-
2王素英,谢玉春,闵莉.大柴胡汤加减对胆囊胆固醇结石湿热证小鼠FXR/FGF15/FGFR4信号通路的影响[J].中国实验方剂学杂志,2022,28(3):15-24. 被引量:9
-
3张宇峰,陶全,徐雨静,杨晔,尹登科.戊唑醇低剂量暴露对大鼠胆汁酸合成的影响[J].生态毒理学报,2022,17(5):393-400.
-
4闵莉,王素英,章小燕,梁文娜,沈建英,周智慧.加减大柴胡汤对胆固醇结石湿热证小鼠的作用机制[J].中国中西医结合杂志,2023,43(8):975-983.
-
5崔立阳,应丽娜,李瑞芳,孙艳,张振宇,张骏.胆道微生态在胆结石形成过程中的作用研究进展[J].中国基层医药,2024,31(4):636-640.
-
1杨忠伟,冯秀丽,范新平,曹旭东.二尼曼匹克病家系NPC1和NPC2基因突变检测分析[J].实用医学杂志,2013,29(4):526-528. 被引量:1
-
2赵燕,姚有贵.胆固醇7α-羟化酶基因多态性与胆固醇结石病关系的研究[J].中国普外基础与临床杂志,2010,17(1):60-63. 被引量:6
-
3韩天权,蒋兆彦,张圣道.胆石病人肠肝循环途径脂质代谢异常的分子生物学研究进展[J].中华肝胆外科杂志,2008,14(4):219-220. 被引量:8
-
4王严,崔玉峰,王克强.结核性腹膜炎合并海蓝组织细胞增生症1例[J].中华腹部疾病杂志,2001,1(3):222-223.
-
5李勇男,吴硕东,田雨.姜黄素联合胡椒碱在预防小鼠胆囊胆固醇性结石中的作用[J].中国普外基础与临床杂志,2015,22(12):1453-1459. 被引量:5
-
6郑晓丽,简丽萍.NPC1L1生物功能的研究进展[J].特别健康(下),2014(4):402-402.
-
7魏健,江路易,宋保亮.胆固醇的内源合成与小肠吸收[J].生命科学,2015,27(7):847-858. 被引量:13
-
8谢琳刚,周林,蒋利.NPC1L1在高脂血症和动脉粥样硬化中的表达分析[J].现代生物医学进展,2006,6(11):31-33. 被引量:2
-
9肖志辉.Niemann-Pick综合征一家系2例[J].中国优生与遗传杂志,1993,1(4):110-111.
-
10曹小丽,卜碧涛,张宇红.利用Adeasy-1系统构建npcl基因非复制型腺病毒载体并鉴定(英文)[J].中国现代医学杂志,2004,14(23):14-17. 被引量:2